Patent 8420081 was granted and assigned to AbbVie Inc. on April, 2013 by the United States Patent and Trademark Office.
The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.